Karl Anders Axel Swartling

Karl Anders Axel Swartling

No open positions remaining
61 year
Finance
Health Technology
Health Services

Profile

Karl Anders Axel Swartling is currently the Chief Executive Officer at Stena Sessan AB and a Director at Affibody AB. He previously held positions as a Director at Aerocrine AB from 2004 to 2011, a Director at Cellectricon AB, and the Managing Director at Sjätte AP-fonden from 2012 to 2019.
He also served as the Managing Director at Investor Growth Capital AB from 2004 to 2012.
Additionally, he has held various director positions at Newron Sweden AB, Mando AB, Global Health Partner Ltd., Tobii AB, Atlas Antibodies AB, Cambio Healthcare Systems AB, GHP Specialty Care AB, PocketMobile Communications AB, Sörman Intressenter AB, and KTH Holding AB. He started his career as a Principal at Mckinsey & Co., Inc. (Munich).
Mr. Swartling obtained an MBA from Stockholm School of Economics in 1989.

Karl Anders Axel Swartling active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Karl Anders Axel Swartling

CompaniesPositionEnd
Chief Executive Officer 2019-02-28
Chief Executive Officer 2019-02-28
President 2012-01-20
AEROCRINE AB Director/Board Member 2011-11-15
Mckinsey & Co., Inc. (Munich)
Corporate Officer/Principal -
See the detail of Karl Anders Axel Swartling's experience

Training of Karl Anders Axel Swartling

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Electronic Technology

Commercial Services

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Services

Health Services

Electronic Technology

Health Technology

Technology Services

Finance

Health Services

Technology Services

Commercial Services

Finance

Mckinsey & Co., Inc. (Munich)

  1. Stock Market
  2. Insiders
  3. Karl Anders Axel Swartling